Financing the PRP Blood Bag Project
Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of platelet-rich plasmaprotein derived from whole blood, centrifuged to remove red blood cells.
PRP is prepared by taking blood from the person, and then putting it through two stages of centrifugation designed to separate PRP from platelet-poor plasma and red blood cells. This is usually done by the clinic offering the treatment, using commercially available kits and equipment. The resulting substance varies from person to person and from facility to facility, making it difficult to understand how safe and effective any specific use is. Platelet-rich plasma is used in horses for treatment of equine lameness due to tendon and ligament injury, wounds, fractures, bone cysts, and osteoarthritis.
Our client, made an patented innovation on the concept of the PRP Extraction Methods, and have previously been working as a British company had the major issues in its process:
- Virtual Manufacturing Permits
- Own Brand Labeling
- Brexit and its consequences
- High tax rates in England
- High OPEX in England
In his approach to World Business Council, we were supposed to find solutions for his problems. The issues were both in:
In a process of 8 month, the following out comes are obtained:
- a new legal identity for his company is set in Poland.
- The OBL and VM permits are issued
- An Arabic Fund sponsored his idea and 500 K euro at the first phase is raised.
- New EU market is developed for the company